Latest Food and Drug Administration Stories

WASHINGTON, May 1, 2013 /PRNewswire-USNewswire/ -- In a letter sent last week, US Secretary of Health and Human Services Kathleen Sebelius was urged to expedite release of a draft updated Federal fish consumer advisory for public comment. Forty members of the research and environmental health advocacy community signed the letter, including prominent scientists, a former head of FDA and organizations including Consumers Union, NRDC, Environmental Defense, Sierra Club, Environmental...

WASHINGTON, April 30, 2013 /PRNewswire-USNewswire/ -- Anna Higgins, Family Research Council's Director of the Center for Human Dignity released the following statement following the decision today by the Food and Drug Administration to make Plan B available over the counter to girls as young as 15 years old: (Logo: http://photos.prnewswire.com/prnh/20080930/FRCLOGO) "This decision shows an alarming lack of concern for the safety of young girls, the fundamental rights of parents,...

PITTSBURGH, April 30, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has appointed Deborah M. Autor as senior vice president, Strategic Global Quality and Regulatory Policy. Autor joins Mylan from the U.S. Food and Drug Administration (FDA), where she served for 11 years, most recently as deputy commissioner for Global Regulatory Operations and Policy. At Mylan, Autor will focus on further advancing Mylan's efforts to lead the industry in establishing one global...

Collaboration positions wide range of natural health products manufactured by Thorne Research for sale in rapidly expanding Chinese market. SANDPOINT, Idaho, April 30, 2013 /PRNewswire/ -- Thorne Research, Inc., a leader in developing and manufacturing pure, high-quality nutritional supplements and personal care products, today announced that the company has entered a joint venture with YouCare Pharmaceutical Group Co. Ltd., a leading Chinese pharmaceutical company located in...

Product provides patients with benefits of home hemodialysis and greater treatment flexibility based on their clinical and lifestyle needs LAWRENCE, Mass., April 30, 2013 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that the U.S. Food and Drug Administration (FDA) has cleared new high flow capabilities with the NxStage System One(TM), the only truly portable hemodialysis system cleared for home use....

Super-Sweet Food Additive Never Approved by FDA to be Safe WASHINGTON, April 30, 2013 /PRNewswire/ -- A lobbying group representing the manufacturers of High Fructose Corn Syrup (HFCS) has acknowledged that an illegal food additive called HFCS-90 is being sold to food and beverage makers even though the substance has never been tested to be safe or approved for sale by the Food & Drug Administration. In a letter posted by the FDA on April 6th, 2013, J. Patrick Mohan, President of the...

As rates of prescription drug abuse steadily climb, the painkiller epidemic is brought to light through the very public face of the NFL. Malibu, CA (PRWEB) April 29, 2013 The prescription drug epidemic has been making headlines recently as the statistics regarding abuse rates continue to increase, and now the latest group being highlighted is the professional football community. In a recent article by The Washington Post, the NFL’s trend of painkiller use and abuse has led many NFL...

Second FDA approval in four months demonstrates Putney's deep scientific capabilities PORTLAND, Maine, April 29, 2013 /PRNewswire/ -- Putney, Inc., a rapidly growing pharmaceutical company focused on the development and sale of generic prescription medicines for pets, has launched Enrofloxacin Flavored Tablets, the first and only FDA approved veterinary generic of Baytril® Taste Tabs®. Putney's Enrofloxacin Flavored Tablets are indicated for the management of diseases associated...

Consumer questions about legal eligibilities to seek compensation over alleged serious side effects from use of popular antibiotic can be answered through free consultations offered by nationwide team of attorneys. San Diego, CA (PRWEB) April 28, 2013 http://www.resource4thepeople.com/defectivedrugs/Zithromax-lawsuits.html Resource4thePeople announced today that it is following up on the recent warning issued by the Food and Drug Administration concerning alleged links between the popular...

The Firm is currently investigating Actos lawsuits on behalf of individuals who developed bladder cancer, allegedly due to long-term use of the type 2 diabetes drug. New York, New York (PRWEB) April 28, 2013 The Actos lawyers at Bernstein Liebhard LLP note that the next Status Conference for thousands of Actos lawsuits currently pending in U.S. District Court, Western District of Louisiana, has been scheduled for May 28th. Court records indicate that Takeda Pharmaceuticals has been...